Claudia K. Fox

2 months ago | nature.com | Ashley H. Shoemaker |Amy Gross |Claudia K. Fox

AbstractAppetitive traits have a central role in energy intake and development of obesity. Child Eating Behavior Questionnaire (CEBQ) is a validated psychometric tool to measure appetitive traits in children. This study sought to assess the CEBQ factor structure in children with obesity. We hypothesized that hedonic traits are more prominent with obesity and in older children. This cross-sectional observational study used CEBQ data from three geographically diverse centers in children with obesity.

Sep 12, 2024 | childrenshealthdefense.org | Claudia K. Fox

Girls May Be Starting Puberty Earlier Due to Chemical Exposure: StudyThe Hill reported:Girls exposed to certain chemicals that are common ingredients in household products may be starting puberty comparatively early, a new study has found. Substances of particular concern include musk ambrette — a fragrance used in some detergents, perfumes and personal care products — and a group of medications called cholinergic agonists, according to the study, published on Tuesday in Endocrinology.

Sep 11, 2024 | medscape.com | Claudia K. Fox

The glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide is the first in its class to show benefits in young children with obesity, according to results from the phase 3a SCALE-KIDS trial presented at the European Association for the Study of Diabetes (EASD) 2024 Annual Meeting and simultaneously published in the New England Journal of Medicine.

Sep 11, 2024 | healio.com | Michael Monostra |Erik Swain |Claudia K. Fox

You've successfully added Obesity in Endocrinology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Children receiving once-daily liraglutide 3 mg had a 5.8% decrease in BMI at 56 weeks. Adverse events were similar to what was seen in adult and adolescent trials.

Sep 11, 2024 | healthday.com | Robin Foster |Claudia K. Fox

WEDNESDAY, Sept. 11, 2024 (HealthDay News) -- The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report. The findings, published Tuesday in the New England Journal of Medicine and presented simultaneously at the European Association for the Study of Diabetes annual meeting in Madrid, are the first to demonstrate the effects of liraglutide (Saxenda) on children ages 6 to 11.